Riesgos por COVID-19 durante la gestación, el efecto de la obesidad materna
Resumen
Actualmente, la información sobre COVID-19, obesidad y embarazo sigue teniendo limitaciones. Al inicio de la epidemia y de acuerdo con la experiencia previa con otros coronavirus como SARS y MERS, se esperaban un mal pronóstico para mujeres embarazadas con obesidad que adquirían la enfermedad. La obesidad es un proceso inflamatorio crónico y de bajo grado, que se ha visto asociada a peores desenlaces durante el embarazo y COVID-19. La distribución del tejido adiposo visceral tiene el peor pronóstico y las gestantes con obesidad tienen mayor riesgo de complicaciones graves. El objetivo de este trabajo fue revisar la evidencia del efecto de la obesidad y COVID-19 en el embarazo.
Descargas
Citas
Huan H, Qingfeng M, Cong L, Rui L, Li Z, Wei W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1124-30.
Vega RG, Rico RM. Adipose tissue: immune function and alterations caused by obesity. Rev Alerg Méx. 2019;66(3):340-53.
Ovalle A, Martínez MA, Fuentes A, Marques X, Vargas F, Vergara P, et al. Obesity, a risk factor for ascending bacterial infection during pregnancy. Rev méd Chile. 2016;144(4):476-82.
McCartney SA, Kachikis A, Huebner EM, Walker CL, Chandrasekaran S, Adams WK. Obesity as a contributor to immunopathology in pregnant and non-pregnant adults with COVID-19. Am J Reprod Immunol. 2020;84:13320.
Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Obesity a risk factor for increased COVID 19 prevalence, severity and lethality (Review). Mol Med Rep. 2020;22(1):9-19.
Panahi L, Amiri M, Pouy S. Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review. Arch Acad Emerg Med. 2020;8(1):34.
Suárez-Carmona W, Sánchez-Oliver AJ, González-Jurado JA. Fisiopatología de la obesidad: Perspectiva actual. Rev Chil Nutr. 2017;44(3):226-33.
Engin AB. Adipocyte-Macrophage Cross-Talk in Obesity. Adv Exp Med Biol. 2017;960:327-43.
Michalakis K, Ilias I. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes Metab Syndr. 2020;14(4):469-71.
Robertson SA, Petroff MG, Hunt JS. Immunology of pregnancy. Knobil and Neill's Physiology of Reproduction. 2015:1835-74.
Salazar TL, Ávila GD. Inmunología perinatal. FEMINA. 2014;42(4):186-92.
Aghaeepour N, Ganio EA, Mcilwain D, Tsai AS, Tingle M, Van GS, et al. An immune clock of human pregnancy. Sci Immunol. 2017;2(15):2946.
Herrera-Pérez JC, Monterio-Fonseca J, Campos-Sánchez S. COVID-19 y embarazo. Rev Méd Sinerg. 2020;5(9):492.
Encuesta Nacional de Salud y Nutrición 2018-19. Resultados nacionales. [Available from: https://ensanut.insp.mx/encuestas/ensanut2018/informes.php.
Rasmussen KM, Yaktine AL, Institute of Medicine (U.S.). Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009. xiv, 854 p. p.
Guerendiain M. Impact of maternal obesity on fetal metabolic programming. Latin Perinat. 2016;19(2):152-6.
Mejia MJ, Reyna VE. Obesidad, insulinorresistencia e hipertensión durante el embarazo. Rev Venez Endocrinol Metab. 2017;15(3):169-81.
Stefan N, Birkenfeld AL, Schulze MB, al. e. Obesidad y deterioro de la salud metabólica en pacientes con COVID-19. Nat Rev Endocrinol. 2020;16:341-2.
Yang J, HU J, Zhu C. Obesity aggravates COVID-19: A systematic review and meta-analysis. J Med Virol. 2020;93(1):257-61.
Petersen A, Bressem K, Albrecht J, Thieb H, Vahldiek J, Hamm B, et al. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectorial pilot study in Germany. Metabolism Clinical and Experimental. 2020;110:317.
Watanabe M, Caruso D, Tuccinardi D, Risi R, Zerunian M, Polici M, et al. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19. Metabolism. 2020;111:319.
Favre G, Legueult K, Pradier C, Raffaelli C, Ichai C, Iannelli A, et al. Visceral fat is associated to the severity of COVID-19. Metabolism. 2020;115:440.
Wastnedge E, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021;101(1):303-18.
Takemoto M, Menezes MO, Andreucci CB, Knobel R, Sousa L, Katz L, et al. Clinical characteristics and risk factors for mortality in obstetric patients with severe COVID-19 in Brazil: a surveillance database analysis. BJOG. 2020;127(13):1618-26.
Martinelli I, Ferrazzi E, Ciavarella A, Blasi F, Mosca F, Peyvandi F. Pulmonary embolism in a young pregnant woman with COVID-19. Thrombosis R. 2020;191:36-7.
Hayakawa S, Komine-Aizawa S, Gil GM. Covid-19 pandemic and pregnancy. Obstetrics and Gynaecology Research. 2020;46(10):1958-66.
Pitones RV, Chávez CE, Hurtado CA, González RA, Serafín HN. Is periodontal disease a risk factor for severe COVID-19 illness? 2020;144:109969.
Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Maternal death due to COVID-19. Am J Obstet Gynecol. 2020;223(1):109 e1- e16.
Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kharbanda EO, Ryan DS, et al. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics. CDC. 2020;69(38):1355-9.
Thompson LJ, Nguyer ML, Noble NK, Aronoff MD. COVID-19-related disease severity in pregnancy. Am J Reprod Immunol. 2020;84:13339.
Novoa RH, Quintana W, Llancarí P, Urbina-Quispe K, Guevara-Ríos E, Ventura W. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review. Travel Med Infect Dis. 2020;39:101919.
Barbero P, Muguerza L, Herraiz I, García BA, San Juan R, Forcén L. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19. J Matern Fetal Neonatal Med. 2020;34(4):30951-7.
Boushra MN, Koyfman A, Long B. COVID-19 in pregnancy and the puerperium: A review for emergency physicians. Am J Emerg Med. 2020;20(30951):735-6757.
